Viewing Study NCT02825160


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-02-25 @ 6:42 PM
Study NCT ID: NCT02825160
Status: COMPLETED
Last Update Posted: 2024-08-19
First Post: 2016-06-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension, Pulmonary View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Iloprost View
None Ventavis View
None Prostacycline analogue View
None Pulmonary arterial hypertension View
None Japan View
None Post-marketing surveillance View